US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist

65.350
+0.910+1.41%

Close Dec 20 16:00 ET

65.956
+0.606+0.93%

Post 20:01 ET

202.63BMarket Cap31.49P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AstraZeneca Q3 2024 Earnings Date

Currency：USDNov 12, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	13.10B	13.57B	+462.53M
Beat Est.	+14.01%	+18.04%	+3.53%
EPS	0.77	0.46	-0.32
Miss Est.	+73.46%	+3.41%	-41.05%

Analyst Rating

Strong Buy

Dec 12, 2024

AstraZeneca Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 13.535B	--
--	2024/Q4	-- / 14.237B	--
Nov 12, 2024	2024/Q3	13.565B / 13.102B	--
--	2024/Q2	12.938B / 12.528B	--
Apr 25, 2024	2024/Q1	12.679B / 11.812B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 13.535B--

--2024/Q4-- / 14.237B--

Nov 12, 20242024/Q313.565B / 13.102B--

--2024/Q212.938B / 12.528B--

Apr 25, 20242024/Q112.679B / 11.812B--

Unlock Free Earnings Estimates

Open Account

AstraZeneca Earnings Reports

6-K: 9M and Q3 2024 Results

Nov 12 13:43 ET

6-K: AstraZeneca Invests $3.5 Billion in US

Nov 12 09:28 ET

6-K: H1 and Q2 2024 Results

Jul 25 09:09 ET

AstraZeneca | 6-K: AstraZeneca to Deliver $80bn Revenue by 2030

May 21 06:10 ET

Trending US Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 12, 2024

Strong Buy

Buy
83.33%
Hold
16.67%
Sell
0.00%

Price Target

No Data

Investment Theme

Infectious Disease

Intraday+0.78%